BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aleynik SI, Leo MA, Ma X, Aleynik MK, Lieber CS. Polyenylphosphatidylcholine prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis. J Hepatol. 1997;27:554-561. [PMID: 9314134 DOI: 10.1016/s0168-8278(97)80361-3] [Cited by in Crossref: 86] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Ghareeb DA, Hafez HS, Hussien HM, Kabapy NF. Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction. Metab Brain Dis. 2011;26:253-267. [PMID: 21881966 DOI: 10.1007/s11011-011-9261-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
2 Li L, Yang Y, Zhang Z, Nie S, Li Z, Li F, Hua H, Hu Y, Zhang H, Guo Y. Protective effects of medical ozone combined with traditional Chinese medicine against chemically-induced hepatic injury in dogs. WJG 2007;13:5989. [DOI: 10.3748/wjg.v13.45.5989] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 Lu M, Qiu Q, Luo X, Liu X, Sun J, Wang C, Lin X, Deng Y, Song Y. Phyto-phospholipid complexes (phytosomes): A novel strategy to improve the bioavailability of active constituents. Asian J Pharm Sci 2019;14:265-74. [PMID: 32104457 DOI: 10.1016/j.ajps.2018.05.011] [Cited by in Crossref: 45] [Cited by in F6Publishing: 26] [Article Influence: 15.0] [Reference Citation Analysis]
4 Iimuro Y, Brenner DA. Matrix metalloproteinase gene delivery for liver fibrosis. Pharm Res. 2008;25:249-258. [PMID: 17577645 DOI: 10.1007/s11095-007-9311-7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
5 Amália PM, Possa MN, Augusto MC, Francisca LS. Quercetin prevents oxidative stress in cirrhotic rats. Dig Dis Sci. 2007;52:2616-2621. [PMID: 17431769 DOI: 10.1007/s10620-007-9748-x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 3.7] [Reference Citation Analysis]
6 Chamulitrat W, Zhang W, Xu W, Pathil A, Setchell K, Stremmel W. Hepatoprotectant ursodeoxycholyl lysophosphatidylethanolamide increasing phosphatidylcholine levels as a potential therapy of acute liver injury. Front Physiol 2012;3:24. [PMID: 22363296 DOI: 10.3389/fphys.2012.00024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
7 Khan RA, Khan MR, Sahreen S. CCl4-induced hepatotoxicity: protective effect of rutin on p53, CYP2E1 and the antioxidative status in rat. BMC Complement Altern Med 2012;12:178. [PMID: 23043521 DOI: 10.1186/1472-6882-12-178] [Cited by in Crossref: 92] [Cited by in F6Publishing: 85] [Article Influence: 10.2] [Reference Citation Analysis]
8 Zhang CF, Zhang CQ, Zhu YH, Wang J, Xu HW, Ren WH. Ginkgo Biloba Extract EGb 761 Alleviates Hepatic Fibrosis and Sinusoidal Microcirculation Disturbance in Patients with Chronic Hepatitis B. Gastroenterology Res 2008;1:20-8. [PMID: 27994702 DOI: 10.4021/gr2008.10.1220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
9 Cao HX, Sun H, Jiang XG, Lu HT, Zhang GM, Wang XJ, Sun WJ, Wu ZM, Wang P, Liu L. Comparative study on the protective effects of Yinchenhao Decoction against liver injury induced by alpha-naphthylisothiocyanate and carbon tetrachloride. Chin J Integr Med. 2009;15:204-209. [PMID: 19568713 DOI: 10.1007/s11655-009-0204-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
10 Medina J, Moreno-Otero R. Pathophysiological basis for antioxidant therapy in chronic liver disease. Drugs. 2005;65:2445-2461. [PMID: 16296871 DOI: 10.2165/00003495-200565170-00003] [Cited by in Crossref: 121] [Cited by in F6Publishing: 92] [Article Influence: 8.1] [Reference Citation Analysis]
11 Wang LW, Wang LK, Chen H, Fan C, Li X, He CM, Gong ZJ. Ethyl pyruvate protects against experimental acute-on-chronic liver failure in rats. World J Gastroenterol. 2012;18:5709-5718. [PMID: 23155311 DOI: 10.3748/wjg.v18.i40.5709] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
12 Naz K, Khan MR, Shah NA, Sattar S, Noureen F, Awan ML. Pistacia chinensis: a potent ameliorator of CCl₄ induced lung and thyroid toxicity in rat model. Biomed Res Int 2014;2014:192906. [PMID: 25180176 DOI: 10.1155/2014/192906] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
13 Alkreathy HM, Khan RA, Khan MR, Sahreen S. CCl4 induced genotoxicity and DNA oxidative damages in rats: hepatoprotective effect of Sonchus arvensis. BMC Complement Altern Med. 2014;14:452. [PMID: 25412679 DOI: 10.1186/1472-6882-14-452] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
14 Ikeda R, Ishii K, Hoshikawa Y, Azumi J, Arakaki Y, Yasui T, Matsuura S, Matsumi Y, Kono Y, Mizuta Y. Reactive oxygen species and NADPH oxidase 4 induced by transforming growth factor β1 are the therapeutic targets of polyenylphosphatidylcholine in the suppression of human hepatic stellate cell activation. Inflamm Res. 2011;60:597-604. [PMID: 21318733 DOI: 10.1007/s00011-011-0309-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
15 He SX, Luo JY, Wang YP, Wang YL, Fu H, Xu JL, Zhao G, Liu EQ. Effects of extract from Ginkgo biloba on carbon tetrachloride-induced liver injury in rats. World J Gastroenterol 2006;12:3924-8. [PMID: 16804984 DOI: 10.3748/wjg.v12.i24.3924] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
16 AlSaid M, Mothana R, Raish M, Al-Sohaibani M, Al-Yahya M, Ahmad A, Al-Dosari M, Rafatullah S. Evaluation of the effectiveness of Piper cubeba extract in the amelioration of CCl4-induced liver injuries and oxidative damage in the rodent model. Biomed Res Int 2015;2015:359358. [PMID: 25654097 DOI: 10.1155/2015/359358] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
17 Rockey DC. Current and future anti-fibrotic therapies for chronic liver disease. Clin Liver Dis 2008;12:939-62, xi. [PMID: 18984475 DOI: 10.1016/j.cld.2008.07.011] [Cited by in Crossref: 112] [Cited by in F6Publishing: 99] [Article Influence: 9.3] [Reference Citation Analysis]
18 Valentino G, Zivko C, Weber F, Brülisauer L, Luciani P. Synergy of Phospholipid-Drug Formulations Significantly Deactivates Profibrogenic Human Hepatic Stellate Cells. Pharmaceutics 2019;11:E676. [PMID: 31842373 DOI: 10.3390/pharmaceutics11120676] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Lu P, Liu H, Yin H, Yang L. Expression of angiotensinogen during hepatic fibrogenesis and its effect on hepatic stellate cells. Med Sci Monit. 2011;17:BR248-BR256. [PMID: 21873937 DOI: 10.12659/MSM.881928] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]